Here, we provide evidence for the targeted anticancer activity of PB against BRCA1 mutated breast cancer cells in vitro as well as in GEMM (Genetically Engineered Mouse Models) of BRCA1 mutated mammary tumor. Here, BRCA1 is linked to breast cancer.